Data Reveals Sustained Local Control for Early Stage Lung Cancer Patients Who Receive SBRT

Share this content:
Data reveals sustained local control for early stage lung cancer patients who receive SBRT
Data reveals sustained local control for early stage lung cancer patients who receive SBRT
Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
READ FULL ARTICLE From News Medical
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »